A detailed history of Farther Finance Advisors, LLC transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 25 shares of SAGE stock, worth $137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$137
Previous $276,000 34.42%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$10.58 - $17.9 $148 - $250
14 Added 127.27%
25 $276,000
Q4 2023

Feb 14, 2024

BUY
$17.1 - $22.26 $68 - $89
4 Added 57.14%
11 $238,000
Q3 2023

Nov 13, 2023

BUY
$16.75 - $48.98 $117 - $342
7 New
7 $144,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.